Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate the safety and efficacy of thrombolysis in combination with endhole aspiration in the treatment of acute deep vein thrombosis (DVT). Secondarily, the study team hope to illuminate the financial implications of single session catheter directed therapy versus a potential 48 hour lysis procedure (Lysis is an approach in which vascular specialists deliver clot-dissolving drugs directly to the site of the clot through a catheter).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04297787
Study type Interventional
Source University of Kansas Medical Center
Contact
Status Completed
Phase N/A
Start date September 23, 2020
Completion date June 16, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03504007 - Registry of Patients Prescribed Anticoagulation
Completed NCT00911157 - The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients Phase 3
Completed NCT00480636 - Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients N/A
Completed NCT02148029 - Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome N/A